IRIS
SALA, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.080
AS - Asia 2.448
EU - Europa 2.017
Continente sconosciuto - Info sul continente non disponibili 375
SA - Sud America 320
AF - Africa 56
OC - Oceania 3
Totale 9.299
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.970
SG - Singapore 1.166
IT - Italia 639
CN - Cina 520
VN - Vietnam 313
IE - Irlanda 300
BR - Brasile 257
RU - Federazione Russa 235
SE - Svezia 196
DE - Germania 136
GB - Regno Unito 93
IN - India 92
UA - Ucraina 91
TR - Turchia 78
FR - Francia 77
BD - Bangladesh 71
HK - Hong Kong 63
FI - Finlandia 62
CA - Canada 56
PL - Polonia 31
NL - Olanda 29
AT - Austria 26
JP - Giappone 25
ZA - Sudafrica 25
AR - Argentina 22
BE - Belgio 20
MX - Messico 19
IQ - Iraq 18
ES - Italia 15
CZ - Repubblica Ceca 12
EC - Ecuador 12
AE - Emirati Arabi Uniti 11
KR - Corea 11
MY - Malesia 11
EG - Egitto 10
PK - Pakistan 10
CH - Svizzera 9
UZ - Uzbekistan 9
VE - Venezuela 9
JO - Giordania 8
LT - Lituania 8
CR - Costa Rica 7
GR - Grecia 7
JM - Giamaica 7
MA - Marocco 6
PY - Paraguay 6
DK - Danimarca 4
DZ - Algeria 4
ID - Indonesia 4
IL - Israele 4
LK - Sri Lanka 4
NI - Nicaragua 4
RS - Serbia 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CL - Cile 3
CO - Colombia 3
GD - Grenada 3
HR - Croazia 3
HU - Ungheria 3
KE - Kenya 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
TW - Taiwan 3
AL - Albania 2
AU - Australia 2
BB - Barbados 2
HN - Honduras 2
IR - Iran 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
MQ - Martinica 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 8.916
Salva come PNG Salva come JPEG
Città #
Singapore 871
San Jose 491
Chandler 411
Ashburn 332
Dublin 297
Dallas 211
Jacksonville 179
Beijing 174
Council Bluffs 131
Princeton 114
Santa Clara 110
The Dalles 108
Los Angeles 105
New York 95
Ho Chi Minh City 90
Ann Arbor 85
Chieti 80
Pescara 64
Hanoi 57
Hong Kong 56
Altamura 52
Boardman 48
Munich 48
Nanjing 48
Dearborn 44
Buffalo 37
Izmir 36
Dong Ket 35
Columbus 34
Wilmington 34
Orem 33
St Louis 30
Moscow 29
Rome 29
Warsaw 27
Atlanta 26
Phoenix 26
Redondo Beach 26
Denver 25
Milan 25
Montreal 25
Houston 24
São Paulo 24
Tongling 23
Frankfurt am Main 22
Hefei 22
Southend 22
Tokyo 22
Lappeenranta 21
Brussels 20
Da Nang 19
Johannesburg 19
Seattle 19
Turku 19
Washington 19
Chicago 18
Brooklyn 17
Cambridge 16
Stockholm 16
Chennai 14
Nuremberg 14
Haiphong 13
Nanchang 13
Poplar 13
Pune 13
Collecorvino 12
Helsinki 12
London 12
Hebei 11
L’Aquila 11
Mcallen 10
Mexico City 10
Norwalk 10
Seoul 10
Vienna 10
Woodbridge 10
Manchester 9
Mumbai 9
Ninh Bình 9
Rio de Janeiro 9
San Francisco 9
Shanghai 9
Tashkent 9
Boston 8
Montesilvano 8
Petaling Jaya 8
Shenyang 8
Toronto 8
Baghdad 7
Belo Horizonte 7
Castignano 7
Falls Church 7
Zhengzhou 7
Zurich 7
Amman 6
Amsterdam 6
Brasília 6
Brno 6
Campinas 6
Charlotte 6
Totale 5.519
Salva come PNG Salva come JPEG
Nome #
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 238
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 224
Cold atmospheric plasma activated media selectively affects human head and neck cancer cell lines 197
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 186
BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages 179
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma 175
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 175
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 172
ABCC3 is a novel target for the treatment of pancreatic cancer 170
ERBB3 BINDING ANTIBODY 163
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 163
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction. 158
Humanized anti-bag3 antibodies 157
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 156
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma 154
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 154
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 154
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 154
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 153
CAF-Derived IL6 and GM-CSF Cooperate to Induce M2-like TAMs–Letter 143
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools 141
Therapeutic efficacy of the novel stimuli-sensitive nano-ferritins containing doxorubicin in a head and neck cancer model 140
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 137
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 136
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 135
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 134
Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer 134
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 132
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy 130
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 128
Breast cancer in the era of integrating "Omics" approaches 127
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 125
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 119
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 116
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors 116
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. 116
The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1 115
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 114
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies 113
Antibody-drug conjugates: The new frontier of chemotherapy 113
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 113
Engineered human nanoferritin bearing the drug genz-644282 for cancer therapy 112
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 111
Phospholipase Cgamma1 is required for metastasis development and progression 111
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. 110
The E27 β2-adrenergic receptor polymorphism reduces the risk of myocardial infarction in dyslipidemic young males 110
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines 109
Human head and neck cancer cell lines response to cold atmospheric plasma activated media is affected by the chemistry of culture media 107
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation 106
The role of phospholipase Cγ1 in breast cancer and its clinical significance 103
The role of phosphoinositide 3-kinase C2α in insulin signaling 101
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers 99
A phosphoinositide 3-kinase/phospholipase cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation 99
Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth 98
HER-3: Hub for escape mechanisms 97
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 95
Endosialin-binding antibody 95
Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S-Methyl-DM4 94
Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control 93
Feedback inhibition by RALT controls signal output by the ErbB network 91
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 88
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin 88
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 84
MYC regulates metabolism through vesicular transfer of glycolytic kinases 84
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 83
Negative regulation of receptor tyrosine kinase signals 83
P63 role in breast cancer 81
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 76
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target 76
Role of BAG3 in cancer progression: A therapeutic opportunity 73
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 72
New analytical challenges in characterization of Antibody-Drug Conjugates 71
Galectin-3-binding protein is a risk factor for Diabetes, Metabolic Syndrome, and Inflammation. Cross-sectional and Longitudinal Results from the InCHIANTI study 70
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans 68
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review 65
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 48
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 33
BAG3 in human tumors 28
null 21
null 7
Totale 9.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.914
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022316 0 0 5 62 18 12 13 23 29 20 28 106
2022/20231.065 94 175 71 124 92 176 49 89 129 12 38 16
2023/2024638 38 15 64 33 36 214 97 26 5 25 13 72
2024/20251.657 60 301 242 66 45 74 71 74 218 130 228 148
2025/20263.933 284 134 372 450 422 238 718 207 371 381 217 139
2026/2027445 96 292 57 0 0 0 0 0 0 0 0 0
Totale 9.299